Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 5,560.00
-50.00 (-0.89%)
Sep 19, 2025, 9:40 AM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 538.76 billion as of September 18, 2025. Its market cap has decreased by -32.85% in one year.
Market Cap
538.76B
Enterprise Value
506.58B
Revenue
1.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,560.00
Market Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 538.76B, an increase of 1,034.38%. That is a compound annual growth rate of 11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 544.53B | -3.08% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1,038.98B | -4.44% |
| Dec 29, 2022 | 1,087.24B | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | 1,048.68B | 115.45% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.24T |
| Celltrion | 37.10T |
| ALTEOGEN | 25.28T |
| Yuhan | 8,752.85B |
| SK Biopharmaceuticals | 8,410.84B |
| Peptron | 6,744.58B |
| PharmaResearch | 6,431.19B |
| ABL Bio | 5,452.05B |